Quidel Corp. (NASDAQ:QDEL) shares traded up 1.3% during mid-day trading on Wednesday . The stock traded as high as $21.93 and last traded at $21.84, with a volume of 64,475 shares traded. The stock had previously closed at $21.55.

Several research analysts have recently issued reports on the company. Zacks Investment Research raised Quidel Corp. from a “hold” rating to a “buy” rating and set a $26.00 price target for the company in a research note on Friday, July 29th. Canaccord Genuity reissued a “hold” rating on shares of Quidel Corp. in a research note on Thursday, April 28th. Raymond James Financial Inc. raised Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price target for the company in a research note on Monday, June 13th. Finally, TheStreet cut Quidel Corp. from a “hold” rating to a “sell” rating in a research note on Friday, May 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $21.58.

The stock’s market capitalization is $697.40 million. The firm’s 50-day moving average is $21.25 and its 200 day moving average is $18.03.

Quidel Corp. (NASDAQ:QDEL) last announced its quarterly earnings data on Wednesday, July 27th. The company reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.25) by $0.14. The firm had revenue of $39.10 million for the quarter, compared to analyst estimates of $37.98 million. During the same period in the previous year, the business posted ($0.14) EPS. Quidel Corp.’s revenue for the quarter was up 11.1% compared to the same quarter last year. Equities analysts forecast that Quidel Corp. will post ($0.14) EPS for the current fiscal year.

In related news, SVP John Tamerius sold 7,000 shares of the firm’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $23.02, for a total transaction of $161,140.00. Following the completion of the transaction, the senior vice president now owns 18,540 shares in the company, valued at approximately $426,790.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Robert Joseph Bujarski sold 22,057 shares of the firm’s stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $22.58, for a total value of $498,047.06. Following the transaction, the senior vice president now owns 60,100 shares of the company’s stock, valued at approximately $1,357,058. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Quidel Corp. stock. Schwab Charles Investment Management Inc. increased its stake in Quidel Corp. (NASDAQ:QDEL) by 11.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,410 shares of the company’s stock after buying an additional 10,002 shares during the period. Schwab Charles Investment Management Inc. owned 0.30% of Quidel Corp. worth $2,108,000 as of its most recent filing with the SEC.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.